CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or "off the shelf†, cell therapies for serious medical conditions, today announced the initiation of a new islet cell transplant program in Type 1 Diabetes (T1D). Specifically, the company aims to deploy its manufacturing capability to address the issue of large-scale production of islet cells, with the ini ...

Scotiabank analyst Greg McGinniss sets a new price target of $43 for NASDAQ:LINE, indicating a potential upside of 5.94%.The stock's volatility is highlighted by its year-long fluctuation between $84.86 and $38.83.Rosen Law Firm encourages investors to seek legal counsel ahead of a lead plaintiff deadline, potentially affecting investor sentiment and stock performance.Lineage, Inc. (NASDAQ: LINE) is a company that has recently caught the attention of investors and analysts alike. On September 5, 2025, Greg ...

Core Viewpoint - Rosen Law Firm is reminding purchasers of Lineage, Inc. common stock about the September 30, 2025 lead plaintiff deadline for a class action lawsuit related to the company's July 2024 IPO [1]. Group 1: Class Action Details - Investors who purchased Lineage common stock may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by September 30, 2025 [3]. - The lawsuit claims that the registration statement was false and/or misleading, failing to disclose significant issues affecting Lineage's business operations and financial results [5]. Group 2: Allegations Against Lineage - The lawsuit alleges that Lineage experienced a sustained weakening in customer demand due to increased cold-storage supply and destocking of excessive inventory by customers [5]. - It is claimed that Lineage implemented unsustainable price increases prior to the IPO, which could not be maintained in the face of weakening demand [5]. - The company reportedly could not counteract adverse trends through operational efficiencies or competitive advantages, leading to stagnant or falling revenue, occupancy rates, and rent prices [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Rosen Law Firm has been recognized for its leadership in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013 [4].

Core Viewpoint - A lawsuit has been filed against Lineage, Inc. and its senior executives for potential violations of federal securities laws related to its IPO and subsequent financial performance [1][2]. Group 1: Lawsuit Details - Investors have until September 30, 2025, to request to lead the case, which is based on claims under Sections 11 and 15 of the Securities Act of 1933 [2]. - The lawsuit is pending in the U.S. District Court for the Eastern District of Michigan, specifically titled City of St. Clair Shores Police and Fire Retirement System v. Lineage, Inc., et al. [2]. Group 2: Company Overview - Lineage, Inc. operates as a cold storage-focused real estate investment trust (REIT), owning and managing temperature-controlled storage facilities for perishable products [3]. Group 3: Allegations and Financial Performance - The IPO documents claimed that Lineage had "consistent cold chain demand" and strong cash flows, suggesting resilience during economic stress, while the reality was a downturn due to customers destocking excess inventory from the pandemic [4]. - Following the IPO on July 25, 2024, at $78 per share, Lineage's stock price has significantly declined to around $40 per share, approximately 50% of its initial value [5].

Core Viewpoint - A class action securities lawsuit has been filed against Lineage, Inc. alleging securities fraud related to its initial public offering (IPO) on July 26, 2024 [1][2]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors who purchased Lineage common stock in connection with the IPO [2]. - The complaint alleges that Lineage made false statements and concealed critical information regarding its financial health and market conditions [3]. Group 2: Allegations Against Lineage - Lineage reportedly faced a decline in customer demand due to increased cold-storage supply and a shift in customer inventory strategies post-COVID-19 [3]. - The company had implemented unsustainable price increases prior to the IPO, which could not be maintained amid weakening demand [3]. - Lineage was unable to counteract adverse trends through operational efficiencies or competitive advantages, leading to stagnant or declining revenue and occupancy rates [3]. - The financial results and business prospects of Lineage were materially impaired as a result of these issues [3]. Group 3: Next Steps for Investors - Investors who suffered losses during the relevant timeframe have until September 30, 2025, to request appointment as lead plaintiff [4]. - Participation in the lawsuit does not require any out-of-pocket costs for class members [4]. Group 4: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured significant recoveries for shareholders over the past 20 years [5].

Core Viewpoint - A class action securities lawsuit has been filed against Lineage, Inc. due to alleged securities fraud affecting investors who purchased shares during the company's initial public offering on July 26, 2024 [1][2]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors adversely affected by false statements and omissions made by Lineage, Inc. regarding its financial health and operational performance [2][3]. - Allegations include that Lineage was experiencing a decline in customer demand, leading to destocking of excessive inventory and a shift to leaner cold-storage inventories [3]. - The complaint asserts that Lineage's price increases prior to the IPO were unsustainable due to weakening demand, and the company could not counteract these adverse trends through operational efficiencies or competitive advantages [3]. Group 2: Financial Impact - Contrary to representations made in the registration statement, Lineage was reportedly suffering from stagnant or declining revenue, occupancy rates, and rent prices, rather than enjoying stable growth [3]. - The lawsuit claims that Lineage's financial results, business operations, and future prospects were materially impaired as a result of the alleged misrepresentations [3]. Group 3: Next Steps for Investors - Investors who suffered losses during the relevant timeframe have until September 30, 2025, to request appointment as lead plaintiff in the lawsuit [4]. - Participation in the lawsuit does not require any out-of-pocket costs or fees for class members [4]. Group 4: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [5]. - The firm is recognized as one of the top securities litigation firms in the United States, with extensive expertise in complex securities cases [5].

Group 1 - The Rosen Law Firm is reminding purchasers of Lineage, Inc. common stock about the September 30, 2025 lead plaintiff deadline related to the class action lawsuit following Lineage's July 2024 IPO [1][3] - Investors who purchased Lineage common stock may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2][5] - The lawsuit claims that the registration statement issued during the IPO was misleading, failing to disclose significant issues such as weakening customer demand and unsustainable price increases [5] Group 2 - The lawsuit alleges that Lineage was experiencing stagnant or falling revenue, occupancy rates, and rent prices, contrary to the representations made in the registration statement [5] - The Rosen Law Firm has a strong track record in securities class actions, having recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4] - Investors interested in joining the class action can find more information through the Rosen Law Firm's website or by contacting their representatives [3][6]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Lineage, Inc. regarding a class action lawsuit related to the company's initial public offering (IPO) on July 26, 2024, alleging that the company made materially false and misleading statements about its financial health and business operations [1][3][4]. Allegations - The lawsuit claims that during the class period, Lineage experienced a significant decline in customer demand due to increased cold-storage supply and a destocking of excessive inventory by customers, which was built up during the COVID-19 pandemic [4]. - It is alleged that Lineage implemented unsustainable price increases prior to the IPO, which could not be maintained in the face of weakening demand [4]. - The company reportedly failed to counteract adverse trends through operational efficiencies or competitive advantages, leading to stagnant or declining revenue, occupancy rates, and rent prices, contrary to representations made in the registration statement [4]. - As a result of these issues, Lineage's financial results and business prospects were materially impaired [4]. Next Steps for Shareholders - Shareholders who purchased shares of Lineage during the specified class period are encouraged to register for the class action by September 30, 2025, to potentially be appointed as lead plaintiffs [5]. - Once registered, shareholders will receive updates on the case through a portfolio monitoring software [5].

Core Viewpoint - The lawsuit against Lineage, Inc. alleges that the company misled investors regarding its financial health and operational performance during the class period surrounding its IPO on July 26, 2024 [2]. Allegations - The complaint claims that Lineage experienced a decline in customer demand due to increased cold-storage supply and destocking of excess inventory from the COVID-19 pandemic [2]. - It is alleged that the company raised prices prior to the IPO, which could not be sustained amid weakening demand [2]. - Lineage reportedly failed to counteract adverse trends through operational efficiencies or competitive advantages [2]. - Contrary to claims of stable revenue growth and high occupancy rates, the company was allegedly facing stagnant or declining revenue, occupancy rates, and rent prices [2]. - As a result of these issues, Lineage's financial results and business prospects were significantly impaired [2]. Class Action Details - Shareholders who purchased Lineage shares during the specified class period are encouraged to register for the class action by September 30, 2025 [3]. - Registration allows shareholders to receive updates on the case and does not require any cost or obligation [3]. Law Firm Information - The Gross Law Firm is recognized for its commitment to protecting investors' rights against deceit and fraud in business practices [4].

Core Viewpoint - A lawsuit has been filed against Lineage, Inc. and its senior executives for potential violations of federal securities laws related to its IPO and subsequent financial performance [1][2]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Eastern District of Michigan, specifically titled City of St. Clair Shores Police and Fire Retirement System v. Lineage, Inc., et al., No. 2:25-cv-12383 [2]. - Investors who purchased stock during Lineage's IPO on July 25, 2024, are encouraged to seek additional information and may have legal options [2][6]. Group 2: Company Overview - Lineage, Inc. operates as a cold storage-focused real estate investment trust (REIT), owning and managing temperature-controlled storage facilities for perishable products [3]. - The company claimed in its IPO documents that it had "consistent cold chain demand," which was expected to provide strong cash flows even during economic downturns [4]. Group 3: Financial Performance and Market Reaction - Following the IPO, Lineage's stock price has significantly declined from an initial price of $78 per share to around $40 per share, approximately half of its IPO value [5]. - In its fiscal Q4 2024 results announced on February 26, 2025, Lineage indicated that customers were "unwinding" excess inventory, returning to a more normal seasonal pattern [5].